Palvella Therapeutics PVLA
NASDAQ PVLA
$163.94 -4.77 (-2.83%)
At close: Nov 11, 2026 · 4:00 PM EST

Palvella Therapeutics (PVLA) Price to FCF (2017 - 2024)

Updated

Palvella Therapeutics' Price to FCF came in at 1.46 for Q3 2024, down 10.4% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Price to FCF (2017 - 2024) Analysis & Trends

For FY2017, Palvella Therapeutics' Price to FCF was 568.79.

  • The Q3 2024 figure represents the lowest quarterly Price to FCF in data going back to Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Palvella Therapeutics 2.47 Bn 2.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.46
Jun 30, 2024 1.63
Sep 30, 2018 18,023.09
Jun 30, 2018 430.03
Mar 31, 2018 554.20
Dec 31, 2017 568.79
Sep 30, 2017 444.44
Jun 30, 2017 2,314.71
Mar 31, 2017 1,031.19
API Access

Palvella Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=PVLA&period=max&api_key=YOUR_API_KEY